» Authors » Carlos Jerjes-Sanchez

Carlos Jerjes-Sanchez

Explore the profile of Carlos Jerjes-Sanchez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 552
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Porres-Aguilar M, Rosovsky R, Rivera-Lebron B, Kaatz S, Mukherjee D, Anaya-Ayala J, et al.
J Thromb Haemost . 2022 Jul; 20(11):2457-2464. PMID: 35895858
Pulmonary embolism response teams (PERTs) have emerged as a multidisciplinary, multispecialty team of experts in the care of highly complex symptomatic acute pulmonary embolism (PE), with a centralized unique activation...
12.
Jerjes-Sanchez C, Glenn-Valdez H, Zayas N, Cueto-Robledo G, Bonola L, Pech-Alonso B, et al.
Arch Med Res . 2022 Apr; 53(4):352-358. PMID: 35487793
Pulmonary arterial hypertension (PAH) is a severe clinical condition that significantly affects patients' quality of life and survival. Since the emergence of prostanoids 45 years ago, different drugs acting on...
13.
Khan A, White R, Meyer G, Pulido Zamudio T, Jerjes-Sanchez C, Johnson D, et al.
Respir Med . 2022 Feb; 193:106744. PMID: 35134631
Oral treprostinil has been shown to improve exercise capacity and delay disease progression in patients with pulmonary arterial hypertension (PAH), but its effects on hemodynamics are not well-characterized. The FREEDOM-EV...
14.
Castillo-Perez M, Jerjes-Sanchez C, Castro-Varela A, Paredes-Vazquez J, Vazquez-Garza E, Ramos-Cazares R, et al.
Thromb J . 2021 Dec; 19(1):101. PMID: 34911551
Background: To our knowledge, the treatment, outcome, clinical presentation, risk stratification of patients with venous thromboembolism and COVID-19 have not been well characterized. Methods: We searched for systematic reviews, cohorts,...
15.
Gonzalez-Urquijo M, Gonzalez-Rayas J, Castro-Varela A, Hinojosa-Gonzalez D, Ramos-Cazares R, Vazquez-Garza E, et al.
Vascular . 2021 Dec; 30(6):1107-1114. PMID: 34866506
Objective: Few studies have focused on arterial thrombosis and acute limb ischemia in COVID-19. This international registry intended to study the spectrum of clinical characteristics, therapeutic trends, and outcomes in...
16.
Bernal-Ramirez J, Diaz-Vesga M, Talamilla M, Mendez A, Quiroga C, Garza-Cervantes J, et al.
Oxid Med Cell Longev . 2021 Sep; 2021:9993060. PMID: 34497685
The right and left ventricles have traditionally been studied as individual entities. Furthermore, modifications found in diseased left ventricles are assumed to influence on right ventricle alterations, but the connection...
17.
Bernal-Ramirez J, Silva-Platas C, Jerjes-Sanchez C, Ramos-Gonzalez M, Vazquez-Garza E, Chapoy-Villanueva H, et al.
Oxid Med Cell Longev . 2021 Jul; 2021:9912434. PMID: 34239697
Pulmonary arterial hypertension (PAH) is characterized by pulmonary vessel remodeling; however, its severity and impact on survival depend on right ventricular (RV) failure. Resveratrol (RES), a polyphenol found in red...
18.
Castillo-Perez M, Jerjes-Sanchez C, Rodriguez D, Paredes-Vazquez J, Panneflek J, Vazquez-Guajardo M
J Thromb Thrombolysis . 2021 Mar; 52(1):260-271. PMID: 33665765
Pulmonary embolism (PE) is a significant cause of death in the very elderly (≥ 75 years) population. Ultrasound-assisted catheter-directed thrombolysis (USCDT) emerges to improve thrombolysis safety and efficacy. However, outcomes...
19.
Betancourt-Del Campo H, Jerjes-Sanchez C, Castillo-Perez M, Lopez-de la Garza H, Paredes-Vazquez J, Flores-Sayavedra Y, et al.
Eur Heart J Case Rep . 2021 Feb; 4(6):1-8. PMID: 33634226
Background: From asymptomatic patients to severe acute respiratory distress syndrome, COVID-19 has a wide range of clinical presentations, and venous thromboembolism has emerged as a critical and frequent complication. Case...
20.
Gibbs H, Freedman B, Rosenqvist M, Virdone S, Al Mahmeed W, Ambrosio G, et al.
Am J Med . 2021 Feb; 134(7):893-901.e11. PMID: 33607088
Background: Asymptomatic atrial fibrillation is often detected incidentally. Prognosis and optimal therapy for asymptomatic compared with symptomatic atrial fibrillation is uncertain. This study compares clinical characteristics, treatment, and 2-year outcomes...